Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)

Last updated: January 23, 2025
Sponsor: Baylor Research Institute
Overall Status: Active - Recruiting

Phase

N/A

Condition

Stroke

Cardiac Disease

Coronary Artery Disease

Treatment

Group Lifestyle Balance for People Post Stroke (GLB-CVA)

Clinical Study ID

NCT06569121
BSW IRB# 024-414
  • Ages 18-85
  • All Genders

Study Summary

Investigators will conduct a randomized controlled trial (RCT) to assess intervention efficacy of telehealth delivery of the GLB-CVA (tGLB-CVA) compared to a 6-month wait-list control (WLC) in partnership with a diverse group of patient partners and peer mentors.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Body Mass Index ≥25

  • All types of stroke

  • Able to Participate in Physical Activity

  • ≥12 months post first stroke

  • Have internet, phone, or computer access, or be willing to use one provided by thestudy team

Exclusion

Exclusion Criteria:

  • Contraindications for physical activity

  • Low Cognitive Function

  • Residing in hospital, acute rehab, skilled nursing facility

  • Not fluent in the English language

  • Pre-existing eating disorder

  • Pregnancy

Study Design

Total Participants: 94
Treatment Group(s): 1
Primary Treatment: Group Lifestyle Balance for People Post Stroke (GLB-CVA)
Phase:
Study Start date:
December 07, 2024
Estimated Completion Date:
December 31, 2029

Connect with a study center

  • Baylor Scott & White Research Institute

    Dallas, Texas 75204
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.